Daxor Corp
NASDAQ:DXR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Daxor Corp
Net Issuance of Debt
Daxor Corp
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Daxor Corp
NASDAQ:DXR
|
Net Issuance of Debt
-$730.2k
|
CAGR 3-Years
26%
|
CAGR 5-Years
9%
|
CAGR 10-Years
27%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Issuance of Debt
-$491m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Net Issuance of Debt
$1.6B
|
CAGR 3-Years
50%
|
CAGR 5-Years
10%
|
CAGR 10-Years
42%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Net Issuance of Debt
-$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-83%
|
CAGR 10-Years
-14%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daxor Corp
Glance View
Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.
See Also
What is Daxor Corp's Net Issuance of Debt?
Net Issuance of Debt
-730.2k
USD
Based on the financial report for Dec 31, 2025, Daxor Corp's Net Issuance of Debt amounts to -730.2k USD.
What is Daxor Corp's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 10Y
27%
Over the last year, the Net Issuance of Debt growth was -2 741%. The average annual Net Issuance of Debt growth rates for Daxor Corp have been 26% over the past three years , 9% over the past five years , and 27% over the past ten years .
